Advertisements

Takeda gets China"s approval for $62 billion Shire purchase

Takeda gets China"s approval for $62 billion Shire purchase.....»»

Category: global-financeSource: reutersSep 14th, 2018

Tencent lost $140 billion in market-cap over delay in approval for #39;Fortnite#39; game: Report

Tencent lost $140 billion in market-cap over delay in approval for #39;Fortnite#39; game: Report.....»»

Category: topSource: moneycontrolAug 27th, 2018

Qualcomm ends $44 billion NXP bid after failing to win China approval

Qualcomm ends $44 billion NXP bid after failing to win China approval.....»»

Category: global-financeSource: reutersJul 26th, 2018

NXP to repurchase $5 billion shares after Qualcomm deal falls through

NXP to repurchase $5 billion shares after Qualcomm deal falls through.....»»

Category: global-financeSource: reutersJul 26th, 2018

Qualcomm scraps $ 45 billion NXP deal after no response from China

Qualcomm scraps $ 45 billion NXP deal after no response from China.....»»

Category: infotechSource: sifyJul 26th, 2018

Qualcomm"s $44 billion NXP offer deadline passes, no word from China

Qualcomm"s $44 billion NXP offer deadline passes, no word from China.....»»

Category: global-financeSource: reutersJul 26th, 2018

Qualcomm investors cheer end of NXP deal doomed by China-U.S. tensions

Qualcomm investors cheer end of NXP deal doomed by China-U.S. tensions.....»»

Category: global-financeSource: reutersJul 25th, 2018

Takeda shareholder group aims to block $62 billion Shire deal

Takeda shareholder group aims to block $62 billion Shire deal.....»»

Category: global-financeSource: reutersJun 11th, 2018

Takeda shareholders group say working to block $62 billion Shire deal

Takeda shareholders group say working to block $62 billion Shire deal.....»»

Category: global-financeSource: reutersJun 11th, 2018

Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal

Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal.....»»

Category: global-financeSource: reutersMay 17th, 2018

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire.....»»

Category: global-financeSource: reutersMay 8th, 2018

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire.....»»

Category: topSource: business-standardMay 8th, 2018

Japan"s Takeda agrees $62 billion takeover of Shire

Japan"s Takeda agrees $62 billion takeover of Shire.....»»

Category: global-financeSource: reutersMay 8th, 2018

Takeda closes in on Shire deal with sweetened $64-billion offer

Takeda closes in on Shire deal with sweetened $64-billion offer.....»»

Category: global-financeSource: business-standardApr 25th, 2018

Analysis: Shire bid marks Takeda"s latest - and biggest - push for global status

Analysis: Shire bid marks Takeda"s latest - and biggest - push for global status.....»»

Category: global-financeSource: reutersApr 25th, 2018

Shire willing to back $64 billion Takeda bid, market signals doubts

Shire willing to back $64 billion Takeda bid, market signals doubts.....»»

Category: global-financeSource: reutersApr 25th, 2018

Shire says willing to recommend Takeda"s $64 billion offer to shareholders

Shire says willing to recommend Takeda"s $64 billion offer to shareholders.....»»

Category: global-financeSource: reutersApr 24th, 2018

Exclusive - Shire, Takeda reach breakthrough in deal talks: sources

Exclusive - Shire, Takeda reach breakthrough in deal talks: sources.....»»

Category: global-financeSource: reutersApr 24th, 2018

Toshiba eyes cancelling chip unit sale if no China approval by May - media

Toshiba eyes cancelling chip unit sale if no China approval by May - media.....»»

Category: global-financeSource: reutersApr 22nd, 2018

Takeda shares drop after Shire rejects $63 bln offer

Takeda shares drop after Shire rejects $63 bln offer.....»»

Category: global-financeSource: reutersApr 19th, 2018

Shire rejects $63 billion Takeda bid as Allergan drops pursuit

Shire rejects $63 billion Takeda bid as Allergan drops pursuit.....»»

Category: global-financeSource: reutersApr 19th, 2018